Evotec News and Activities

Presence

Evotec develops and manufactures pharmaceutical and biotechnology solutions. Its main services include drug discovery, development support, and advanced manufacturing for pharmaceutical, biotechnology, and healthcare partners.

Evotec products and services overview:

Drug discovery
Development services
Biologics manufacturing
Cell therapy
Gene therapy
Research services

Revenue: ~$850 million

Employees: 5,000

Headquarters: Hamburg, Germany

Evotec is one of the...

Evotec is a company listed under the stock ticker EVTCY (DE).

Executives

View the org chart displaying its 36 main executives

Most searched biographies at Evotec

Popular executive movements at Evotec

Rui Wang has joined the company as Head of Global In Silico and artificial intelligence (posted on June 3 2026).
Paul Hitchin, Chief Financial Officer, will leave the company on Apr. 30, 2026 (posted on April 24 2026).
Claire Hinshelwood will join the company as Chief Financial Officer on May 1, 2026 (posted on April 24 2026).

Click here to view some more movements at Evotec

Create your alert
to follow the executive moves at Evotec.